SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-98-003824
Filing Date
1998-11-13
Accepted
1998-11-13 00:00:00
Documents
7
Period of Report
1998-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 93735
2 AMENDMENT TO FORM OF STOCK OPTION AGREEMENT EX-3.04 13607
3 AMENDMENT TO FORM OF RESTRICTED SHARE AGREEMENT EX-3.05 13610
4 FORM OF CHANGE IN CONTROL SEVERANCE AGREEMENT EX-10.65 26441
5 SEVERANCE PROVISIONS EX-10.66 2043
6 COMPUTATION OF EARNINGS (LOSS) PER SHARE EX-11.4 2261
7 FINANCIAL DATA SCHEDULE EX-27.4 2217
  Complete submission text file 0000950133-98-003824.txt   155901
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 98748107
SIC: 2834 Pharmaceutical Preparations